drugset / Trial / NCT01161459

Treatment of Idiopathic Membranous Nephropathy With Tripterygium Wilfordii Plus Steroid vs Tacrolimus Plus Steroid

NCT01161459

Completed 100 enrolled Zhi-Hong Liu, M.D.
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is: To explore the potential role of Tripterygium wilfordii plus steroid in the treatment of membranous nephropathy. To investigate the safety and tolerability of Tripterygium wilfordii plus steroid

Timeline

Start
2010-06
Primary completion
2012-04
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tacrolimus Small molecule
Subject tripterygium wilfordii Traditional medicine (herbal / TCM) 60 mg Oral
Background Prednisone Other / unclassified 30 mg